1 |
Krcmery and Gould (1999)8
|
Slovakia |
Antibiotic policies in Central/Eastern Europe (CEE) after 1990 |
Institution of regulation (antibiotic committees) |
Time series analysis |
1994–7 |
Antibiotic consumption (number of antibiotic packages/year) |
Moderate |
Overall decrease of antibiotic consumption: ∼11 000 packages/year in 1994 to ∼ 9000 packages/year in 1997 |
2 |
Altunsoy et al. (2011)10
|
Turkey |
The impact of a nationwide antibiotic restriction programme on antibiotic usage and resistance against nosocomial pathogens in Turkey |
Institution of regulation (antibiotic committees) |
Pre–post study |
2001–5 |
|
Moderate |
11.3% decrease in antibiotic consumption (g) and cost
|
Negative correlation between ceftriaxone consumption (−36.8%) and the prevalence of ceftriaxone-resistant Escherichia coli and Klebsiella spp. (ρ −0.395, P=0.332 and ρ −0.627, P=0.037); all non-significant |
Decreased use of carbapenems was correlated with decreased carbapenems-resistant Pseudomonas spp. and Acinetobacter spp (ρ 0.155, P=0.712; ρ 0.180, P=0.668) |
Methicillin resistance rates of S. aureus decreased from 44% to 41% |
3 |
Nathwani et al. (2011)9
|
Scotland, UK |
Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme |
Institution of regulation (antibiotic committees) |
Time series analysis |
2005–9 |
|
Moderate |
44 500 fewer prescriptions in 2009 compared with 2008
Penicillin combinations (co-amoxiclav): 14.7% decrease in items per 1000 population/day
Fluoroquinolones: 7.1% decrease in items per 1000 population/day; ≤5% seasonal variation in fluoroquinolone use
Cephalosporins: 21.2% decrease in items per 1000 population/day
|
Increased number of NHS boards achieving ≥95% compliance with the empirical prescribing policy (range: 65%–89%) |
4 |
Tao et al. (2013)11
|
China |
Analysis of the current situation of antibiotics use in China: a hospital-based perspective |
Institution of regulation (antibiotic committees) |
Time series analysis |
2008–11 |
|
Moderate |
Percentage of drug sales for antimicrobials decreased from 23.8% (2009) to 19.4% (2011) |
Sales volume for second- (24.51% to 9.46%) and third-line (21.54% to 4.78%) antibiotics decreased from 2010 to 2011, while sales volume for first-line antibiotics increased from 2010 to 2011 (7.96% to 13.94%) |
5 |
Xiao et al. (2013)12
|
China |
Changes in Chinese policies to promote the rational use of antibiotics |
Institution of regulation (antibiotic committees) |
Time series analysis |
2009–12 |
|
Moderate |
Percentage of drug sales for antimicrobials decreased from 25% (2011) to 17% (2012) |
Percentage of antimicrobial prescriptions decreased in both inpatient settings (68% versus 58%) and outpatient settings (25% versus 15%) |
6 |
Malmvall et al. (2007)17
|
Sweden |
Reduction of antibiotics sales and sustained low incidence of bacterial resistance: report on a broad approach during 10 years to implement evidence-based indications for antibiotic prescribing in Jönköping County, Sweden |
Institution of regulation (antibiotic committees) |
Time series analysis |
1993–2005 |
|
Moderate |
31% decrease in overall antibiotic consumption: 15.9 DDD in 1993 to 11.0 DDD in 2005
|
No increase in the prevalence of resistant pneumococci or Haemophilus influenzae in the county |
7 |
Zhang et al. (2017)13
|
Tianjin, China |
Effectiveness of antibiotic use management in Tianjin (2011–2013): a quasi-experimental study |
Institution of regulation (antibiotic committees) |
Quai-experimental study |
2011–13 |
Antibiotic consumption (percentage of antibiotic use in inpatients; DDD per 100 patient days) |
Moderate |
Decrease in percentage of antibiotic use by inpatients (%): 60.38% in 2011 to 46.88% in 2013, P<0.000 |
Decrease in DDD/100 patient days: 51.60 DDD in 2011 to 35.37 DDD in 2013, P<0.000 |
8 |
Mölstad et al. (1999)14
|
Sweden |
Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA) |
Institution of regulation (antibiotic committees) |
Time series analysis |
1980–97 |
Antibiotic consumption (DDD per 1000 inhabitants/day) |
Moderate |
Decrease in DDD per 1000 inhabitants/day: 16.3 DDD in 1993 to 13.0 DDD in 1997
|
9 |
Mölstad et al. (2008)15
|
Sweden |
Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish STRAMA programme |
Institution of regulation (antibiotic committees) |
Time series analysis |
1987–2004 |
|
Moderate |
Decrease in DDD per 1000 inhabitants/day: 15.7 DDD in 1995 to 12.6 DDD in 2004 |
Decrease in number of prescriptions per 1000 inhabitants per year: 536 prescriptions in 1995 to 410 prescriptions in 2004
|
National frequency of penicillin-resistant S. pneumoniae increased from 4% to 6% despite decrease in antibiotic use among children |
Resistance in S. pneumoniae also increased to erythromycin, tetracyclines and co-trimoxazole between 1994 and 2004 |
Rate of ampicillin-resistant E. coli in urinary cultures increased from 17% to 24%, trimethoprim-resistant E. coli increased from 8% to 15% from 1997–2004 |
10 |
Zou et al. (2014)16
|
China |
Is nationwide special campaign on antibiotic stewardship programme effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011–2012 |
Institution of regulation (antibiotic committees) |
Pre–post study |
2011–12 |
Antibiotic consumption (DDD per 100 inpatient days; percentage of antibiotic use in outpatient and inpatient cases) |
High |
Decrease in DDD per 100 patient days: 39.37 DDD in 2011 to 26.54 DDD in 2012, P<0.001 |
Decrease in percentage of antibiotic use in outpatient cases: 24.12% in 2011 to 18.71% in 2012, P=0.109 |
Decrease in percentage of antibiotic use in inpatient cases: 64.85% in 2011 to 60.10% in 2012, P=0.006 |
11 |
Allouch et al. (2016)7
|
Lebanon |
Antibiotic use, cost, and consumption in tertiary hospitals in Lebanon: a comparative study before and after an implementation of antibiotic-restriction program (ARP) |
Institution of regulation (clinical guidelines) |
Retrospective cohort study |
March–June 2013 |
|
Moderate |
Decreases in proportional consumption of third-generation cephalosporins (19% to 12%, P<0.001), increase in the consumption of penicillin derivatives (24% to 28%, P<0.001). |
Decrease in rate of restricted antibiotic use: 37.1% versus 26.1%, P<0.0001 |
22.3% decrease in the expenditure on all antibiotics (P<0.001). |
12 |
Goosens et al. (2008)19
|
Belgium |
Achievements of the Belgian Antibiotic Policy coordination committee (BAPCOC) |
Institution of regulation (clinical guidelines); public education campaigns |
Time series analysis |
1999–present |
Antibiotic consumption (number of reimbursed packages per 1000 inhabitants per day)
Hospitals with key structural resources and tools in place for effective antibiotic management and infection control
Incidence of nosocomial acquisition of MRSA among patients admitted to acute care hospitals
Resistance rate
Compliance with hand hygiene
|
High |
90% of hospitals had key structural resources and tools in place for effective antibiotic management and infection control |
35% relative reduction from 2004 to 2008 in the incidence of nosocomial acquisition of MRSA among patients admitted to acute care hospitals |
36% decrease in number of reimbursed packages per 1000 inhabitants per day |
Increased compliance with hand hygiene: 49% to 69% in 2005; 53% to 69% in 2007 |
Decrease in resistance rates from 2000 to 2007
Penicillin resistance in S. pneumoniae decreased from ∼16% to ∼10%
Tetracycline resistance in S. pneumoniae decreased from 32% to 22%
Erythromycin resistance in S. pneumoniae decreased from 37% to 25%
Macrolide resistance in Streptococcus pyogenes decreased from 17% in 2001 to 2% in 2007
|
13 |
Tambić-Andršević (2009)20
|
Croatia |
Antibiotic resistance control in Croatia |
Prescribing restrictions |
Time series analysis |
2003–8 |
Antibiotic consumption (DDD per 1000 inhabitants/day) |
High |
Decrease in DDD per 1000 inhabitants/day (outpatient): 23.6 DDD in 2003 to 22.6 DDD in 2008 |
Decrease in DDD per 1000 inhabitants/day (inpatient): 2.5 DDD in 2002 to 1.5 DDD in 2008 |
14 |
Conly (2012)18
|
Canada |
Antimicrobial resistance programs in Canada 1995–2010: a critical evaluation |
Prescribing restrictions; public education campaigns |
Time series analysis |
1995–2010 |
Antibiotic consumption (oral antimicrobial prescriptions per 1000 inhabitants) |
High |
Decrease in oral antimicrobial prescriptions per 1000 inhabitants: 25.3% decrease in prescriptions, driven by decreases in β-lactams, sulphonamides and tetracyclines |
15 |
Sørensen and Monnet (2000)21
|
Denmark |
Control of antibiotic use in the community: the Danish experience |
Prescribing restrictions |
Time series analysis |
1995–6 |
Antibiotic consumption (DDD per 1000 inhabitants; percentage of antimicrobial use) |
High |
Decrease in DDD per 1000 inhabitants: 4620 DDD per 1000 inhabitants in 1995 to 4122 DDD in 1996 |
Decrease in tetracycline use: 578 DDD in 1995 to 391 DDD in 1996 |
Decrease in percentage of antimicrobial use: 4.5% reduction in the use of antimicrobials in the primary healthcare sector in 1998 to 1999 |
16 |
Fürst et al. (2015)22
|
Slovenia |
The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications |
Prescribing restrictions; public education campaigns |
Time series analysis |
1995–2012 |
|
Moderate |
Decrease in prescriptions per 1000 inhabitants: 791.29 prescriptions in 1999 to 525.97 prescriptions in 2012 |
Decrease in DDD per 1000 inhabitants/day 20.38 DDD in 1999 to 14.01 DDD in 2012 (P<0.0001); driven by significant decreases in tetracyclines, phenoxymethylpenicillin, cephalosporins and macrolides |
S. pneumoniae resistance to penicillin decreased from 14.5% to 10%. |
S. pneumoniae resistance to macrolides increased from 5.4% to 21% |
17 |
Liou et al. (2015)23
|
Taiwan, China |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors—a nationwide study |
Prescribing restrictions |
Time series analysis |
1997–2008 |
|
Low |
Decrease in DDD per 1000 inhabitants/day (1997 to 2008)
Amoxicillin: 4.12 to 3.69
Tetracycline: 1.79 to 2.06
Macrolides: 1.12 to 0.49
Nitroimidazole: 0.22 to 0.15
Fluoroquinolone: 0.12 to 0.35
|
Primary H. pylori levofloxacin resistance rose from 4.9% in 2000–7 to 8.3% in 2008–10 and to 13.4% in 2011–12, P=0.001 |
18 |
Duborija-Kovačević (2006)24
|
Montenegro |
Antibiotic prescribing policy of the Republic Health Insurance Fund of Montenegro in the period 2000–2004: effects of drug utilization reform strategy |
Prescribing restrictions |
Pre–post study |
2000–4 |
Antibiotic consumption (DDD per 1000 inhabitants/day; percentage of antibiotic prescriptions) |
High |
Decrease in percentage of antibiotic prescription: lower by 12% in 2004 compared with 2000 |
Decrease in DDD per 1000 inhabitants/day: 14.57 DDD in 2004 to 2.80 DDD in 2000
|
19 |
Cheng et al. (2012)25
|
Australia |
Control of fluoroquinolone resistance through successful regulation |
Prescribing restrictions |
Time series analysis |
1992–2010 |
Resistance rates |
High |
Quinolone resistance rates in disease-causing isolates of E. coli increased from 0.4% in 1992 to 4.9% in 2006. Since 2006, surveillance of isolates from community-acquired infections showed a decrease in resistance rates to 4.1% in 2008. |
20 |
Marshall et al. (2006)26
|
Canada |
Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis |
Prescribing restrictions |
Time series analysis |
1999–2002 |
Antibiotic consumption (number of prescriptions per week) |
Low |
Changes in number of antibiotic prescriptions per week
Fluoroquinolones: 1905 fewer prescriptions per week, P<0.0001 between 2000 and 2001; driven by decrease in ciprofloxacin prescription (2084 fewer prescriptions per week, P<0.0001
Nitrofurantoin: 200 more prescriptions per week, P<0.0001
Trimethoprim/sulfamethoxazole: 532 more prescriptions per week, P<0.0001
|
21 |
Kliemann et al. (2016)27
|
Brazil |
Socioeconomic determinants of antibiotic consumption in the state of São Paulo, Brazil: the effect of restricting over-the-counter sales |
Prescribing restrictions |
Time series analysis |
2008–12 |
Antibiotic consumption (DDD per 1000 inhabitants/day) |
Moderate |
Decrease in DDD per 1000 inhabitants/day: 8.44 DDD in 2008 to 8.06 DDD in 2012 |
22 |
Rivas and Alonso (2011)28
|
Venezuela |
Regulation of dispensing drugs and their effect on the consumption of antibiotics in Venezuela |
Prescribing restrictions |
Retrospective study |
2005–8 |
Antibiotic consumption (DDD per 1000 inhabitants/day) |
Moderate |
Decrease in DDD per 1000 inhabitants/day (2005 to 2008)
Diaminopyrimidines–sulfonamides: 1.11 to 1.01
Tetracyclines: 0.45 to 0.44
Aminoglycosides: 0.1357 to 0.1377
Rifampicin: 0.011 to 0.012
Penicillins and first-generation cephalosporins: 6.37 to 8.09
Macrolides and lincosamides: 2.03 to 2.85
Fluoroquinolones: 1.68 to 2.58
Third-generation cephalosporins: 0.15 to 0.34
|
23 |
Chou et al. (2003)29
|
Taiwan |
Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan’s experience |
Separation of antibiotic prescribing from dispensing |
Time series with control group |
1996–9 |
Antibiotic prescription (probability of non-prescription) Average drug dispensing expenditure per visit |
Low |
No significant difference between control and experimental cities: 7% increase in non-prescription probability in antibiotics immediately after the policy was in place, but the effect diminished over time |
Non-significant changes in average drug dispensing expenditure per visit |
24 |
Kim et al. (2016)30
|
South Korea |
Antibiotic control policies in South Korea, 2000–2013 |
Separation of antibiotic prescribing from dispensing |
Time series analysis |
1998–2008 |
Antibiotic consumption (DDD per 1000 inhabitants/day) |
High |
Decrease in DDD per 1000 inhabitants/day: 28.8 DDD in 1998 to 22.8 DDD in 2008 |
25 |
Belongia et al. (2005)31
|
Wisconsin and Minnesota, USA |
Impact of statewide programme to promote appropriate antimicrobial drug use |
Campaigns for healthcare professionals; public education campaigns |
Pre–post study with control |
1998–2003 |
Antibiotic prescription; annual primary care prescriptions of antibiotics per physician |
Low |
Decrease in percentage of annual primary care prescriptions of antibiotics per physician (dividing the number of new filled prescriptions by the number of prescribers per year):
|
26 |
Weiss et al. (2011)32
|
Quebec, Canada |
Impact of a multipronged education strategy on antibiotic prescribing in Quebec, Canada |
Campaigns for healthcare professionals; public education campaigns |
Time series analysis |
2003–7 |
Antibiotic consumption (number of outpatient antibiotic prescriptions per 1000 inhabitants/day) |
Moderate |
Decrease in the number of outpatient antibiotic prescriptions per 1000 inhabitants/day (2003 to 2007):
|
27 |
Chahwakilian et al. (2011)33
|
France |
Impact of the French campaign to reduce the inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections |
Campaigns for healthcare professionals; public education campaigns |
Retrospective cohort study |
2001–9 |
Antibiotic prescription (DDD per 1000 inhabitants/day; number of ambulatory antibiotic prescriptions per 1000 inhabitants/year; proportion of consultations resulting in antibiotic prescriptions)
Number of consultations for respiratory tract infections (RTIs)
|
Moderate |
Decrease in DDD per 1000 inhabitants/day: 35.7 DDD in 2001 to 30.2 DDD in 2009 |
Decrease in the number of ambulatory antibiotic prescriptions per 1000 inhabitants/year
|
23% decrease in the number of consultations for RTIs between 2001 and 2009 |
Decrease in the proportion of consultations resulting in antibiotic prescriptions: 58% in 2001 to 46% in 2009 |
28 |
Plachouras et al. (2014)34
|
Corinth, Greece |
Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece |
Campaigns for healthcare professionals; public education campaigns |
Pre–post study with control |
January–February 2009 |
Antibiotic consumption (DDD per 1000 inhabitants/year; percentage of antibiotic use) |
Moderate |
Increase in DDD per 1000 inhabitants/year: 26 DDD (January–February 2009) to 32 DDD (March 2009) |
Changes in percentage of antibiotic use, P=0.02:
Amoxicillin and penicillin: 34.3% increase
Macrolides: 21.9% decrease
Second-generation cephalosporins: 6.4% decrease
Fluoroquinolones: 21.9% decrease
Amoxicillin clavulanate: 9.4% decrease
|
29 |
Bernier et al. (2014)35
|
France |
Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly |
Campaigns for healthcare professionals; public education campaigns |
Time series analysis |
2000–10 |
Antibiotic prescription (number of weekly antibiotic prescriptions per 1000 inhabitants) |
Moderate |
30% (95% CI −36.3 to −23.8) decrease in weekly antibiotic prescriptions during campaign period; no significant differences during non-campaign period |
21% increase (95% CI 12.9%–29.6%) antibiotic consumption in seniors |
30 |
Hemo et al. (2009)36
|
Israel |
Can a nationwide media campaign affect antibiotic use? |
Campaigns for healthcare professionals; public education campaigns |
Pre–post study |
2004–5; 2005–6 |
Antibiotic consumption (purchasing rates for upper respiratory infection, otitis media and pharyngitis) |
Low |
Decrease in antibiotic purchasing rates for:
Upper RTI (OR=0.75; 95% CI 0.69–0.81)
Otitis media (OR = 0.65; 95% CI 0.59–0.72)
Pharyngitis (OR = 0.93; 95% CI 0.89–0.97)
|
31 |
Lambert et al. (2007)37
|
England |
Can mass media campaigns change antimicrobial prescribing? A regional evaluation study |
Public education campaigns |
Pre–post study |
2004, 2005 |
Antibiotic prescription; antibiotic prescriptions per 1000 STAR-PU (Specific Therapeutic group Age-sex Related Prescribing Units) |
Moderate |
21.7 fewer items prescribed per 1000 population (P<0.0005); 5.8% absolute reduction in prescribing |
32 |
Sabuncu et al. (2009)38
|
France |
Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007 |
Public education campaigns |
Time series analysis |
2002–7 |
Antibiotic prescription; number of antibiotic prescriptions per 100 inhabitants |
Low |
26.5% (95% CI −33.5 to −19.6) decrease in the number of antibiotic prescriptions per 100 inhabitants:
Mean number of all antibiotic prescriptions for all classes decreased (penicillins, cephalosporins, macrolides, cyclines, etc.) except for quinolones
Greatest decline −35.8% (95% CI−48.3% to −23.2%) observed in young children aged 6–15 years.
|
33 |
Parsons et al. (2004)40
|
England |
Did local enhancement of a national campaign to reduce high antibiotic prescribing affect public attitudes and prescribing rates? |
Public education campaigns |
Time series analysis |
1995/6–99/2000 |
Antibiotic prescription; number of antibiotic prescriptions per 1000 patients dispensed between 1995/6 and 1999/2000
Proportion of participants who believed that children should be prescribed antibiotics for a fever
|
Moderate |
Decrease in number of antibiotic prescriptions per 1000 patients: 686 1995/6 to 431 in 1999/2000; not significant |
Decrease in the proportion of responders who believed that children should be prescribed antibiotics for a fever: 56% in 1995/6 to 49% in 1999/2000 |
34 |
Wutzke et al. (2006)39
|
Australia |
Evaluation of a national programme to reduce inappropriate use of antibiotics for upper respiratory tract infections: effects on consumer awareness, beliefs, attitudes and behaviour in Australia |
Public education campaigns |
Time series analysis |
2001–4 (June to August) |
Antibiotic prescription (total antibiotic prescriptions dispensed in the community; total antibiotic prescriptions dispensed for upper respiratory tract infections |
Moderate |
Decrease in total antibiotic prescriptions in the community: 23.08 million antibiotic prescriptions in 1998/9 to 21.44 million in 2001/2 |
Decrease in total antibiotic prescriptions for upper respiratory tract infections: 216 000 fewer prescriptions for upper respiratory tract infections from 2001 to 2003 |